Anxiety. Anxiety disorder due to known physiological condition
Conditions
Interventions
Intervention 1: The first intervention group will receive intranasal dexmedetomidine (Exir Company, Iran) at a dose of 1.5 µg/kg body weight, administered 20 minutes before the induction of anesthesia
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 5 Years
Inclusion criteria
Inclusion criteria: Informed Consent Healthy children 3–5 years of age Need for general anesthesia for dental treatments
Exclusion criteria
Exclusion criteria: Having contraindications for general anesthesia and nasotracheal intubation on the day of procedure/surgery History of hypersensitivity to midazolam or dexmedetomidine Use of sedative or anxiolytic medications within 24 hours prior to the study Severe obesity or severe underweight
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety. Timepoint: The beginning of the study and the end of the study. Method of measurement: Base on Modified Yale Preoperative Anxiety Scale.;Sedation during venipuncture. Timepoint: 20 minutes after drug administration, at the same time as venipuncture. Method of measurement: Base on University of Michigan Sedation Scale.;Heartbeat. Timepoint: Before and after laryngoscopy. Method of measurement: Using monitoring. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNastaran Kaviani
Esfahan University of Medical Sciences
Outcome results
None listed